Status:
NOT_YET_RECRUITING
Efficacy of NOSHINtrial in Diabetic Patients
Lead Sponsor:
Kerman Medical University
Collaborating Sponsors:
Afzalipour Hospital
Conditions:
Diabetes Mellitus, Type 2
Insulin Resistance
Eligibility:
All Genders
20-65 years
Phase:
PHASE4
Brief Summary
The goal of this \[Efficacy of a traditional anti-diabetic herbal drug with on glycemic, inflammatory, and oxidative stress parameters\] is \[investigate the level of HOMA-estimated insulin resistance...
Detailed Description
All the volunteers (Diabetic men and women with HbA1c more than 6.5 from the age of 20 to 65 years who usually use their standard medicine) who meet the entry criteria were directed to the laboratory ...
Eligibility Criteria
Inclusion
- Age between 20 and 65 years
- HbA1c more than 6.5
- Consistency of diet and exercise program
- Body mass index less than 35
- Not receiving insulin
- The patient should take standard medicine except insulin
Exclusion
- Performing CABG surgery, occurrence of ASC, heart and brain stroke, pulmonary embolism, deep vein thrombosis or TIA in the last 1 year.
- Taking anti-inflammatory drugs such as aspirin with an anti-inflammatory dose, antioxidant supplements, vitamins and omega-3 capsules (\<1 g/day), and immunosuppressive drugs in the last three months.
- Presence of cancer, liver and thyroid diseases.
- pregnancy
- Smoking and alcohol consumption
Key Trial Info
Start Date :
September 26 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 16 2027
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06205030
Start Date
September 26 2025
End Date
August 16 2027
Last Update
August 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kerman University of Medical Sciences
Kerman, Iran